March 22, 2018
Last night, the U.S. House of Representatives formally voted to pass federal legislation that would protect the Right to Try for terminally ill patients who want to use medicines awaiting final approval from the Food and Drug Administration.
Similar but separate legislation to protect the Right to Try was approved last year in the U.S. Senate by unanimous consent.
Just last week, the House had narrowly failed to approve its own bill after considering a special motion that required support from at least two-thirds of the representatives.
After that setback, the Goldwater Institute joined with patients, doctors, and other advocates for the Right to Try to keep the momentum going.
So yesterday, the House took up again its Right to Try bill with a new motion that required only a simple majority vote. The House responded by easily approving the legislation with support from Republicans and Democrats alike.
Our grassroots, bipartisan coalition has been working tirelessly since 2013 to build support for healthcare freedom. As a result, 38 states protect your Right to Try under state law.
Now, we will work with Right to Try allies and members of Congress from both parties to reach final approval of legislation that can be sent to the president to sign into federal law.